Semi-Annual Consolidated Statement Of Income

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7353883

Concept 2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
787,000,000 JPY
3,654,000,000 JPY
60,648,000,000 JPY
57,859,000,000 JPY
7,590,000,000 JPY
48,616,000,000 JPY
664,000,000 JPY
54,011,000,000 JPY
51,635,000,000 JPY
2,457,000,000 JPY
43,641,000,000 JPY
7,247,000,000 JPY
Cost of sales
29,294,000,000 JPY
26,249,000,000 JPY
Ordinary profit (loss)
6,100,000,000 JPY
2,113,000,000 JPY
Gross profit (loss)
28,565,000,000 JPY
25,385,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
24,400,000,000 JPY
24,892,000,000 JPY
Extraordinary income
5,032,000,000 JPY
6,879,000,000 JPY
Extraordinary losses
32,000,000 JPY
2,000,000 JPY
Profit (loss) before income taxes
11,100,000,000 JPY
8,990,000,000 JPY
Operating profit (loss)
81,000,000 JPY
214,000,000 JPY
4,113,000,000 JPY
4,164,000,000 JPY
968,000,000 JPY
2,849,000,000 JPY
30,000,000 JPY
398,000,000 JPY
492,000,000 JPY
39,000,000 JPY
-325,000,000 JPY
654,000,000 JPY
Non-operating income
Interest income
39,000,000 JPY
16,000,000 JPY
Dividend income
1,225,000,000 JPY
1,243,000,000 JPY
Gain on sale of securities
540,000,000 JPY
50,000,000 JPY
Non-operating income
2,067,000,000 JPY
1,673,000,000 JPY
Income taxes - current
1,727,000,000 JPY
940,000,000 JPY
Income taxes - deferred
920,000,000 JPY
1,305,000,000 JPY
Non-operating expenses
Interest expenses
13,000,000 JPY
15,000,000 JPY
Non-operating expenses
131,000,000 JPY
52,000,000 JPY
Income taxes
2,648,000,000 JPY
2,246,000,000 JPY
Profit (loss)
8,452,000,000 JPY
6,744,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
12,000,000 JPY
JPY
Extraordinary losses
Profit (loss) attributable to non-controlling interests
115,000,000 JPY
77,000,000 JPY
Profit (loss) attributable to owners of parent
8,337,000,000 JPY
6,667,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
3,455,000,000 JPY
-8,849,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-210,000,000 JPY
-237,000,000 JPY
Other comprehensive income
3,244,000,000 JPY
-9,086,000,000 JPY
Comprehensive income
11,697,000,000 JPY
-2,342,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,570,000,000 JPY
-2,422,000,000 JPY
Comprehensive income attributable to non-controlling interests
126,000,000 JPY
80,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.